We initially determined the survival of patients with breast cancer according to TLR5 gene data using Kaplan–Meier plotter (http://kmplot.com/analysis/) and found significantly worse survival rates among patients with low TLR5 expression in tumors(Fig. 2a). This evidence concerns the gene TLR5 and breast carcinoma.